SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): JULY 14, 2003
EXACT SCIENCES CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE
(State or Other Jurisdiction of Incorporation)
000-32179 02-0478229
(Commission File Number) (IRS Employer Identification No.)
100 CAMPUS DRIVE, MARLBOROUGH MASSACHUSETTS 01752
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (508) 683-1200
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibits
99.1 Press Release dated July 14, 2003.
ITEM 9. REGULATION FD DISCLOSURE
On July 14, 2003, EXACT Sciences Corporation issued a press release, a copy
of which is being filed as Exhibit 99.1 to this Current Report on Form 8-K,
such press release being incorporated herein by reference.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EXACT Sciences Corporation
July 14, 2003 By: /s/ John A. McCarthy, Jr.
-------------------------
John A. McCarthy, Jr.
Executive Vice President, Chief
Operating Officer, Chief Financial
Officer and Treasurer
3
EXHIBIT INDEX
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
99.1 Press Release dated July 14, 2003.